Sulindac suppresses beta-catenin expression in human cancer cells
about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersWnt signaling pathway in non-small cell lung cancerAnti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targetsSulindac Inhibits Canonical Wnt Signaling by Blocking the PDZ Domain of the Protein DishevelledNovel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsWnt signaling in triple negative breast cancer is associated with metastasisAnti-Inflammatory Agents for Cancer Therapy.Tumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of beta-catenin signaling.MicroRNA roles in beta-catenin pathway.Black raspberries inhibit intestinal tumorigenesis in apc1638+/- and Muc2-/- mouse models of colorectal cancerIntervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasisIbuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.MYC and Breast Cancer.Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.Impact of mutant β-catenin on ABCB1 expression and therapy response in colon cancer cellsHIF1α deficiency reduces inflammation in a mouse model of proximal colon cancerSuppression of Wnt/beta-catenin signaling inhibits prostate cancer cell proliferationSulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.A review of the evidence for the canonical Wnt pathway in autism spectrum disorders.NSAIDs and Cell Proliferation in Colorectal Cancer.A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression.Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling.miR-27a-3p targeting RXRα promotes colorectal cancer progression by activating Wnt/β-catenin pathway.COX-2 inhibitors in NSCLC: never-ending story or misplaced?
P2860
Q26739665-B41341B9-EFDD-4EF4-B61D-328814A9A285Q26825936-E7AA8854-6AB8-4591-B189-F64F07882132Q27004250-C655371E-BF66-4876-9F3B-19439EAF9B22Q27656739-9533A2C5-B6FE-4842-8174-53946C8607D1Q28546685-B05E2B75-1206-4808-A4FF-FFBDF9B34F35Q30597238-B59CF7F3-B94F-4FAF-AAB9-BD16D0B03D15Q33744129-C3834870-BC00-412A-9099-CC0FF35CFF5CQ33823652-6504B135-9F6F-41E0-B6C6-BFC137300A94Q34202840-FE174203-961D-4861-B1EC-26D8E73046D7Q34481407-42772BA8-5110-44BD-8746-ED3B51865D55Q34551546-A121B103-33AE-44FB-8ABA-87A7BADF5F9FQ34808205-D81B0F07-DD43-42F6-8D33-FDD7C148DAABQ34972381-E5ACE951-48FB-470C-A7FC-328FBFE0530BQ35870424-E42948E2-5CE7-4EB7-8CE2-A6B2064BF31AQ35892881-AFCF5EDD-1279-4C9D-8701-D6E58FD1E826Q36090805-F6BD8407-E72A-4C81-994E-578BAC45C7D4Q37086749-FC987950-002E-440B-93EA-064845F45AB4Q37238527-537FD258-A1D7-410D-8F4E-9458B1ED3A73Q37536500-32D822F9-240A-42A3-B48B-C1A851AA4E43Q38053503-B6E34644-EE7B-4BB1-80A0-5C3BB2B970F3Q38974369-37A2E9F5-05E8-4BA8-812B-827E9FB92766Q39288546-9922FDFE-C6B9-45D0-AA3B-0AA4428730FAQ40891527-AE747064-9D91-45DA-AF30-447D89C4C749Q47168497-249D5368-D494-4246-B8F0-425B078908A3Q58562551-9B1AE0D0-DED6-4071-8967-B6DA098E2274
P2860
Sulindac suppresses beta-catenin expression in human cancer cells
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Sulindac suppresses beta-catenin expression in human cancer cells
@ast
Sulindac suppresses beta-catenin expression in human cancer cells
@en
Sulindac suppresses beta-catenin expression in human cancer cells
@en-gb
Sulindac suppresses beta-catenin expression in human cancer cells
@nl
type
label
Sulindac suppresses beta-catenin expression in human cancer cells
@ast
Sulindac suppresses beta-catenin expression in human cancer cells
@en
Sulindac suppresses beta-catenin expression in human cancer cells
@en-gb
Sulindac suppresses beta-catenin expression in human cancer cells
@nl
prefLabel
Sulindac suppresses beta-catenin expression in human cancer cells
@ast
Sulindac suppresses beta-catenin expression in human cancer cells
@en
Sulindac suppresses beta-catenin expression in human cancer cells
@en-gb
Sulindac suppresses beta-catenin expression in human cancer cells
@nl
P2093
P2860
P921
P3181
P1476
Sulindac suppresses beta-catenin expression in human cancer cells
@en
P2093
Chang Tong
Leonard H Augenlicht
Wancai Yang
P2860
P3181
P356
10.1016/J.EJPHAR.2007.12.034
P407
P577
2008-03-31T00:00:00Z